Austin Medical Technologies, Inc. Increases Sales by 54% Over Same Period Last Year and 12% Over Prior Quarter in the Current Year.Business Editors/Health/Medical Writers PLANO, Texas--(BUSINESS WIRE)--Sept. 3, 2003 AUSTIN MEDICAL TECHNOLOGIES, Inc. (Pink Sheets:AMTK AMTK Amtrak ), announces that 2nd quarter sales 2003 grew by 54% over prior period last year 2002 and by 12% over prior 1st quarter 2003. This represents an annual revenue growth rate of 140%. Kurt Tarter, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , states, "Our business model is being embraced by our business partners and our value proposition is being well received by our customers. We expect this trend to continue with double-digit sales growth quarter over quarter for the foreseeable future. Our business is a recurring revenue business with 95% retention year after year. Each new contract adds to the current base of business." About Austin Medical Technologies, Inc. Austin Medical Technologies delivers "DIRECT" from the manufacturer to the Doctor, the only technology based, "Single Source Surgical Supply Solution" serving the Ambulatory Surgery Center ambulatory surgery center A free-standing center that performs various types of surgery (ASC ASC Ambulatory surgery center, see there ) market. Under the brand name eyeDirecti, Austin MedTech is initially focused on Ophthalmology owned and operated ASC's which consist of 2,500 practices with 15,000 surgeons performing 4.4 million surgical procedures Surgical procedures have long and possibly daunting names. The meaning of many surgical procedure names can often be understood if the name is broken into parts. For example in splenectomy, "ectomy" is a suffix meaning the removal of a part of the body. "Splene-" means spleen. annually at a supply cost of $400,000,000 per year. Visit our e-commerce site at www.eyedirecti.com. The Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995 provides a "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " for forward-looking statements. Certain information included in this communication (as well as information included in oral statements or other written statements made or to be made by Austin Medical Technologies, Inc. or its wholly owned subsidiaries Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. ) contains statements that are forward-looking, such as statements relating to the future anticipated direction of the medical and technology industries and plans for future expansion, various business development activities, planned capital expenditures, future funding sources, anticipated sales growth and potential contracts. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ from those expressed in any forward-looking statements made by or on behalf of Austin Medical Technologies or its wholly owned subsidiaries. These risks and uncertainties include, but are not limited to, those relating to development and expansion activities, dependence on existing management, financial activities, domestic and global economic conditions, changes in federal or state tax laws, and market competition factors. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion